← All indications
Myocardial Reperfusion Injury
Damage to the MYOCARDIUM resulting from MYOCARDIAL REPERFUSION (restoration of blood flow to ischemic areas of the HEART.) Reperfusion takes place when there is spontaneous thrombolysis, THROMBOLYTIC THERAPY, collateral flow from other coronary vascular beds, or reversal of vasospasm.
Drugs by status
Phase 4 trials (8)
Phase 3 trials (4)
Phase 2 trials (11)
Phase 1 trials (1)
Other trials (4)
Organizations
Organization Involved with Phase 4 Indications (12)
Organization Involved with Phase 3 Indications (5)
Organization Involved with Phase 2 Indications (14)
- Shantou University Medical College
- Newcastle University
- Russian Academy of Medical Sciences
- University of Hull
- Mayo Clinic
- Peking University
- Karolinska Institute
- University of Texas, Galveston
- National Institute for Health Research, United Kingdom
- Beijing Tide Pharmaceutical Co., Ltd
- North of England Medical & Hyperbaric Services
- Shantou University
- People's Liberation Army of China
- The University of Texas, Dallas
Organization Involved with Other Experimental Indications (3)